Company news
ADVANZ PHARMA Corp. Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth
November 18, 2021
Nordic Capital Acquires Specialty Pharmaceutical Company ADVANZ PHARMA in Deal Worth ~$846 Million
June 1, 2021
ADVANZ PHARMA Corp. Limited Announces First Quarter 2021 Results
May 14, 2021
ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2020 Results
March 17, 2021
ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic Capital
January 27, 2021
ADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 Results
November 6, 2020
ADVANZ Pharma Corp. Limited ("ADVANZ" or the "Company") - Formal Sale Process
October 23, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 Results
October 23, 2020
ADVANZ PHARMA Corp. Limited Announces Second Quarter 2020 Results
August 12, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for Second Quarter 2020 Results
July 29, 2020
ADVANZ PHARMA Corp. Limited Announces Results of Annual Meeting of Shareholders
June 17, 2020
Correvio Provides Update Pursuant to BCI 51-515 - Temporary Exemption from Certain Corporate Finance Requirements
June 15, 2020
ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.
May 27, 2020
ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results
May 13, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for First Quarter 2020 Results
April 29, 2020
ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million
April 1, 2020
ADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock Exchange
March 27, 2020
ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 Results
March 25, 2020
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
March 16, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for Fourth Quarter and 2019 Results
March 11, 2020
ADVANZ PHARMA Corp. Limited to Voluntarily Delist from the Toronto Stock Exchange
March 10, 2020
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million
March 6, 2020
ADVANZ PHARMA Corp. Limited Comments on CMA Supplemental Statement of Objections Related to Hydrocortisone Tablets
February 12, 2020
ADVANZ PHARMA Announces Changes to its Board of Directors and Completion of its Continuance to Western Europe
January 8, 2020
ADVANZ PHARMA Corp. Announces Results of Special Meeting of Shareholders
December 17, 2019
ADVANZ PHARMA Corp. Announces Proposal to Re-domicile from Canada to Europe
November 27, 2019
ADVANZ PHARMA Corp. Announces Release Date for Third Quarter 2019 Results
October 24, 2019
ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results
August 7, 2019
ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin
July 25, 2019
ADVANZ PHARMA Corp. Announces Release Date for Second Quarter 2019 Results
July 24, 2019
ADVANZ PHARMA Corp. Announces Results of Annual Meeting of Shareholders
June 17, 2019
ADVANZ PHARMA Corp. Announces Non-Deal Roadshow for European-based Debt Investors
June 11, 2019
ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Prochlorperazine
May 23, 2019
ADVANZ PHARMA Corp. Announces First Quarter 2019 Results
May 10, 2019
ADVANZ PHARMA Corp. Announces Release Date for First Quarter 2019 Results
April 26, 2019
ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines
April 1, 2019
ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results
March 14, 2019
ADVANZ PHARMA Corp. Announces Release Date for Fourth Quarter and 2018 Results
February 21, 2019
ADVANZ PHARMA Corp. Comments on CMA Supplemental Statement of Objections
January 30, 2019
Concordia International Corp. Announces Name Change to ADVANZ PHARMA Corp.
November 29, 2018
Concordia International Corp. Announces Intention To Rebrand As ADVANZ PHARMA Following Its Successful Recapitalization
October 9, 2018
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
September 9, 2016
Concordia Healthcare Completes US$520 Million Public Offering of Common Shares at US$65.00 per Common Share
September 30, 2015
Concordia Healthcare Announces Terms of US$520 Million Public Offering of Common Shares
September 24, 2015
Concordia Healthcare Announces Public Offering of Common Shares
September 21, 2015
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
March 13, 2015
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
September 12, 2014
Decks
- Investor Presentation (June 2019)
Investor deck · 33 slides · June 2019